Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12397 | 0.98 | CYP1A2 (0.42) | CYP1A2HRH3KCNH2CHRM5ADRA2C | |
| SCHEMBL10153844 | 0.84 | CYP1A2 (0.54) | CYP1A2HRH3CHRM5ADRA2CALDH1A1 | |
| SCHEMBL30115020 | 0.83 | ALDH1A1 (0.53) | CYP1A2CHRM5ADRA2CALDH1A1 | |
| SCHEMBL30340999 | 0.82 | CHRM5 (0.58) | CYP1A2HRH3CHRM5ADRA2C | |
| SCHEMBL12945 | 0.82 | CHRM5 (0.58) | CYP1A2HRH3CHRM5ADRA2C | |
| SCHEMBL3218288 | 0.82 | CHRM5 (0.58) | CYP1A2HRH3CHRM5ADRA2C | |
| SCHEMBL27097492 | 0.82 | CHRM5 (0.52) | CYP1A2HRH3CHRM5ADRA2C | |
| SCHEMBL16173593 | 0.82 | HRH3 (0.46) | HRH3KCNH2ADRA2CALDH1A1 | |
| SCHEMBL8587237 | 0.82 | CYP1A2 (0.50) | CYP1A2HRH3CHRM5ADRA2CALDH1A1 | |
| SCHEMBL3951154 | 0.82 | DRD2 (0.37) | CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2499146-B1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO SA (CH) | 2016-09-21 | — | — | EP | disclosed |
| WO-2011058149-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO S.A. (CH) | 2011-05-19 | — | — | WO | disclosed |